The Patent Finder

Terms ending in 2035

Merck Sharp and Dohme LLC

Every in-force patent on Merck Sharp and Dohme LLC's record whose computed term ends in 2035, whoever holds it now. Soonest term end first, then patent number.
PatentTitleHolderStatusExpiresConfidence
US 9,718,808Inhibitors of the Renal Outer Medullary Potassium Channel
In force
 · High confidence
Merck Sharp & Dohme LLCIn forceHigh confidence
US 9,708,336Metallo-Beta-Lactamase Inhibitors
In force
 · High confidence
Merck Sharp & Dohme LLCIn forceHigh confidence
US 10,994,008Modulation of Tumor Immunity
In force
 · High confidence
Merck Sharp & Dohme LLCIn forceHigh confidence
US 10,117,836Tablet Formulation for CGRP Active Compounds
In force
 · High confidence
Merck Sharp & Dohme LLCIn forceHigh confidence
US 11,925,709Tablet Formulation for CGRP Active Compounds
In force
 · High confidence
Merck Sharp & Dohme LLCIn forceHigh confidence
US 12,168,004Treatment of Migraine
In force
 · High confidence
Merck Sharp & Dohme LLCIn forceHigh confidence
US 12,220,408Treatment of Migraine
In force
 · High confidence
Merck Sharp & Dohme LLCIn forceHigh confidence
US 12,310,953Pharmaceutical Formulations for the Treatment of Migraine
In force
 · High confidence
Merck Sharp & Dohme LLCIn forceHigh confidence
US 10,059,667Antidiabetic Compounds
In force
 · High confidence
Merck Sharp & Dohme LLCIn forceHigh confidence
US 10,570,202Combination of a PD-1 Antagonist and a Vegfr Inhibitor for Treating Cancer
In force
 · High confidence
Merck Sharp & Dohme LLCIn forceHigh confidence
153 more term ends in 2035 · Pro
10 of 163 patents shown. Soonest term end first, then patent number.
Pro members see all 163.
Upgrade to Pro
162 of these are in force and held by Merck Sharp and Dohme LLC.
Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited